🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers
National Institute of Allergy and Infectious Diseases (NIAID)’s Post
More Relevant Posts
-
Abstract submissions are open for the 7th annual Children’s National Hospital-NIAID Symposium until July 12! This event, which will take place on September 5 at the Children’s National Research and Innovation Campus in Washington, D.C., will focus on the theme, “A New Paradigm: Infection-Associated Chronic Illnesses Affecting Children.” Submit your abstract, or sign up for free, at https://lnkd.in/es6A3S-e
Join us for the 7th annual Children’s National Hospital-NIAID Symposium! Registration is now open for the September 5 event at the Children's National Hospital Research and Innovation Campus in Washington, D.C., featuring a series of presentations and posters on the theme, “A New Paradigm: Infection-Associated Chronic Illnesses Affecting Children.”
This content isn’t available here
Access this content and more in the LinkedIn app
-
Join us on July 18 for the NIAID Grant Writing Webinar Series. In this series of 6 webinars, we will discuss how to navigate your NIH grant application. This monthly webinar series is free and open to all to pre- and post-doctoral fellows, clinician-scientists, as well as early-stage and mid-career research investigators. Find more information at https://lnkd.in/ebHZA9jn
-
-
Earlier this week, #NIAIDDirector, Dr. Jeanne Marrazzo, met with 1st year clinical fellows during their orientation to give advice on their time in the fellowship. 📸 In this photo, Mitchell Dumais, David Pavkovich, Alexander Hosse, Dr. Marrazzo, Marisol Esqueda, and James Readler appear in the back row (left to right). Kittipos Visitsunthorn and Alexis Katz appear in the front (left to right). #NIAIDTraining #ClinicalFellows #ClinicalFellowship
-
-
A #NIAID-funded study found a gene editing approach removed nearly all latent #HerpesSimplexVirus in a mouse model. This finding could inform development of a cure for people, beyond current suppressive therapies. Learn more: https://lnkd.in/eUmGse-e #HSV
-
-
📢 Applications are still being accepted for a tenure-track/tenure-eligible investigator in the Division of Intramural Research! #ApplyNow at https://go.nih.gov/6zK5ZPO #NIAIDResearch #Scientists
🔬 The Laboratory of Bacteriology at #NIAID seeks an outstanding scientist to serve as a tenure-track investigator. The ideal candidate will have expertise with C. burnetii host-pathogen interactions and be expected to develop a vigorous, independent research program on the biology and pathogenesis of C. burnetii infection. The laboratory aims to identify novel or improved strategies to control bacterial diseases, including developing diagnostics, vaccines, and therapeutics. Applications will be reviewed starting 7/15 until the position is filled. Learn more and #ApplyNow at https://go.nih.gov/6zK5ZPO #JobOpening #NIAIDCareers
-
Kaposi sarcoma herpesvirus (KSHV) associated disorders (KAD) are associated with activation of innate immune processes that cause detrimental inflammation in people with KAD and #HIV, a #NIAID study found. KAD include Kaposi sarcoma, primary effusion lymphoma, KSHV-associated multicentric Castleman disease, and KSHV-inflammatory cytokine syndrome. KAD tend to affect people whose immune systems are suppressed. The findings may inform novel treatments for this complex group of disorders. Learn more: https://lnkd.in/eHMtN6Zf National Cancer Institute (NCI) Image credit: CDC
-
-
New findings published in Nature suggest that bovine (cow) highly pathogenic H5N1 avian influenza (HPAI H5N1) may differ from previous HPAI H5N1 viruses and that these viruses may possess features that could facilitate infection and transmission among mammals. Importantly, however, the viruses currently do not appear capable of efficiently transmitting via the respiratory route among animals or people. Learn more: https://go.nih.gov/6tkKGMA Image credit: Microscopy by CDC; repositioned and recolored by NIAID.
-
-
Scientists have known for decades that malaria infection is associated with high levels of autoantibodies—antibodies that are associated with autoimmune disorders like systemic lupus erythematosus (SLE). In a recent paper, NIAID researchers and their colleagues examine the molecular mechanisms of these autoantibodies, and show how the autoantibodies which are associated with SLE today could once have served a purpose as a defense against malaria. Learn more: https://go.nih.gov/O2rTs4a
-
-
In the July 3, 2024 NIAID Funding News, read a summary of the June meeting of NIAID’s Advisory Council, including newly approved Council concepts. Explore funding for data reuse and research on adverse effects from toxic chemical exposure. Catch up on key presentations from a recent meeting of NIH’s Advisory Committee to the Director. Share feedback on public engagement in clinical research. Know how to locate a grants management specialist when you need help. Plus, get our answers to reader questions about consultant role classification and NIH’s relationship to CDC and FDA. Learn more at https://go.nih.gov/kaIgJ6b
-
